PIK3CA and non-small cell lung carcinoma: BASC expansion and malignant progression in the lung were attenuated by pharmacologic inhibition of PI3K and enhanced by genetic inactivation of Pten. We speculate on the basis of these findings that pharmacologic strategies to inhibit PI3K will be useful in the prevention and treatment of NSCLC.